adamantane has been researched along with Metabolic Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, Y; Hirakawa, Y; Kasuga, JI; Miyachi, H; Morikawa, K; Nagasawa, N; Oyama, T; Toyota, K; Waku, T | 1 |
Kitahara, Y; Miura, K; Yamagishi, S | 1 |
Culler, MD; Halem, H; Potter, BV; Pradaux-Caggiano, F; Su, X; Thomas, MP; Vicker, N | 1 |
3 other study(ies) available for adamantane and Metabolic Diseases
Article | Year |
---|---|
Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures.
Topics: Adamantane; Butyrates; Crystallization; Crystallography, X-Ray; Enzyme Activators; Humans; Hydrocarbons, Fluorinated; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Phenylpropionates; Protein Binding; Protein Conformation; Protein Interaction Domains and Motifs; Protein Isoforms | 2009 |
Combination therapy with nateglinide and vildagliptin improves postprandial metabolic derangements in Zucker fatty rats.
Topics: Adamantane; Animals; Blood Glucose; Cyclohexanes; Drug Therapy, Combination; Fatty Acids; Forkhead Transcription Factors; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Liver; Male; Metabolic Diseases; Nateglinide; Nerve Tissue Proteins; Nitriles; Organ Size; Phenylalanine; Phosphorylation; Postprandial Period; Pyrrolidines; Rats; Rats, Zucker; Triglycerides; Vildagliptin | 2010 |
Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Animals; Cell Line; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; HEK293 Cells; Humans; Hydroxysteroid Dehydrogenases; Kidney; Metabolic Diseases; Mice; Pyridines; Structure-Activity Relationship | 2011 |